The Latest Breaking News from HIV

The head of the U.N. AIDS agency says the sudden loss of American money has been “devastating” for efforts to stop HIV and will cost many lives of the world’s most vulnerable people

Gauri, a 27-year-old transwoman, left her village in Dharashiv district in 2019, to come to Pune in search of a job and start her gender transition. Today, she lives alone in Pune, where she works as a domestic worker in offices and homes. When times are dire, she resorts to…

LGBT+ groups and public health advocates warn against potential threats that could jeopardize progress and ‘set us back decades’

Trump's second term has included pauses to HIV public awareness campaigns and the cancellation of at least 20 grants funding HIV research.

Cuts to foreign aid have resulted in disruptions to life-saving health care in multiple countries

The abrupt halt to US funding threatens to undo decades of advances, dramatically increasing infections and deaths, but some see an opportunity for Africa to lead the response

Christian organizations helped create Pepfar, credited with preventing 25m early deaths, particularly in Africa

Summary Gilead Sciences (GILD) shows strong technical buy signals, with a 19.60% gain since Trend Seeker's buy signal on 1/27 and a 50.31% gain in the last year. The company offers a diverse portfolio of medicines for HIV, COVID-19, liver diseases, oncology, and more, with significant collaborations enhancing its pipeline....

HIV prevention has leaped forward with the development of a yearly injection that may offer long-term protection against the virus. A recent clinical trial has demonstrated promising results, suggesting that this long-acting injectable medication could serve as an effective alternative to daily oral PrEP (Pre-Exposure Prophylaxis). Scientists and medical experts…